in mice cathelicidin-related antimicrobial peptide improved lung bac- terial clearance and survival in response to klebsiella pneumo- niae 31. in humans cross-sectional analyses found that highersibling at home......1.24 .75-2.05 .39ll-37 levels median 36 ngml iqr 28.8-45.9 were associ-smoke exposure at homeantibiotic use before index hospitalizationcorticosteroid use before index hospitalizationvirology......0.58 .30-1.09 .09......0.76 .49-1.19 .23......1.95 1.12-3.41 .02cated with improved forced expiratory volume in one second of expiration 32. moreover in 112 adults hospitalized with community-acquired pneumonia values of serum ll-37 in the lowest tertile overall median 69 ngml range 13-263 ngml were associated with a higher 30-day mortality p  .053 33. in a nested case-control study among individuals initiating chronic hemodialysis n  279 patients with serum cathelici-sole rsv infection ......reference...sole rv infection......0.79 .35-1.79 .57din levels in the lowest tertile had an increased rate of deathdue to infection over 1 year adjusted or 3.7 95 confidencersv  rvcoinfectionrsv  non-rv pathogensrv  non-rsv pathogens......1.44 .81-2.54 .21......1.03 .55-1.92 .92......0.41 .09-1.85 .24interval 1.2-11.2 7.concordant with these results and previous findings in 82 children with bronchiolitis 12 the present data demonstrate an inverse association between serum levels of ll-37 and sever-neither rsv nor rv ......1.19 .63-2.25 .60 nasopharyngeal microbiota profilemoraxella dominant ......reference...ity of illness.

in vitro 125-dihydroxyvi- tamin d increases the transcription of cathelicidin 37 and in vivo vitamin d administration induces cathelicidin 27 28. in the present data and similar to previously reported findings 12table 4. unadjusted and adjusted associations of serum ll-37 levels with respiratory syncytial virus infectionatable 5. unadjusted and adjusted associations of serum ll-37 levels with rhinovirus infectionaserum ll-37 levels and covariatesunadjusted modeladjusted modelbor 95 ci p value or 95 ci p valueserum ll-37 levels and covariatesunadjusted modeladjusted modelbor 95 ci p valueor 95 cip valueserum ll-37 level by quartileserum ll-37 level by quartilelowest 34 ngml0.50 .32-.77 .002c 0.51 .32-.80.003clowest 34 ngml2.41 1.55-3.81 .001c 2.59 1.54-4.36 .001csecond lowest0.45 .29-.69 .001c 0.45 .29-.71.001csecond lowest 34-45.9 ngmlsecond highest2.37 1.53-3.73 .001c 2.41 1.48-3.92 .001c2.14 1.42-3.27 .001c 2.3 1.45-3.65 .001c34-45.9 ngmlsecond highest 46-59.9 ngml0.62 .41-.92.02c 0.64 .43-.97.03c46-59.9 ngmlhighest 60 ngmlreference...reference... covariates age grouphighest 60 ngmlreference...reference... covariates age mo2 mo......reference...raceethnicitynon-hispanic white......reference...non-hispanic white......reference... non-hispanic black......1.22 .81-1.84.34abbreviations ci confidence interval or odds ratio.ainfection with respiratory syncytial virus only or with other viruses.bmixed-effects logistic regression models adjusting for sites as random effects.csignificant at p  .05.abbreviations ci confidence interval or odds ratio.ainfection with rhinovirus only or with other viruses.bmixed-effects logistic regression models adjusting for sites as random effects.csignificant at p  .05.neither 25ohd nor bioavailable 25ohd was related to the quartile of serum ll-37.

ll-37 has direct antiviral effects against rsv 8-10 butithasalso been shown to reduce rv replication in cystic fibrosis cells 11.serum ll-37 in bronchiolitis  cid 201765 15 september  971table 3. unadjusted and adjusted associations of serum ll-37 levels6with hospital length of stayserum ll-37 levels and covariatesunadjusted modeladjusted modelarr 95 cip value rr 95 ci p value4serum ll-37 level by quartilelowest 34 ngml1.52 1.37-1.69 .001b 1.34 1.2-1.49 .001b2covariates age group2 mo......reference...2-5.9 mo......0.65 .59-.71.001b6-12 mo......0.55 .49-.62.001bvirologysole rsv infection......reference...sole rv infection......0.75 .63-.89.001b0050100150serum ll-37 level ngmlfigure 2. locally weighted scatterplot smoothing loess plot showing the rela- tionship between ll-37 as a continuous variable and hospital length of stay as a count variable.

we have also found that the severity of bronchiolitis is related not only to clinical fac- tors 36 but also to the composition of the airway microbiota 21. specifically when compared with a moraxella-dominantneither rsv nor rv ......0.96 .85-1.1.59 nasopharyngeal microbiota profilemoraxella dominant ......reference...airway microbiota infants with a haemophilus-dominant air- way microbiota have more severe bronchiolitis 21 especiallyhaemophilusdominantstreptococcusdominant......1.28 1.15-1.44 .001b......1.01 .91-1.12 .89infants with low serum ll-37 levels 13. taken together the present ll-37 results and previous data about viral-bacterial interactions suggest a complex interplay between the virus themixed......0.91 .82-1.02 .10abbreviations ci confidence interval rr rate ratio rsv respiratory syncytial virus rv rhinovirus.amixed-effects poisson regression model adjusting for sites as random effects.bsignificant at p  .05.our results however show a contrast between the relation of the ll-37 level and the viral etiology.

the viruses that infect infants do so in an airway colonized with bacteria 21 35. indeed we found that children hospital- ized with rsv or rv bronchiolitis have reproducible and dis-rsv  rvcoinfectionrsv  non-rv pathogensrv  non-rsv pathogens......0.95 .85-1.08 .44......0.95 .84-1.08 .46......1.33 1.1-1.62 .004btinct airway microbiota 35 including the rsv-streptococcus association seen in the present data.

shading around the line represents 95 confidence intervals.breathing problems before index hospitalizationever attended daycare......1.34 .79-2.26 .28......0.75 .42-1.34 .33ll-37 is a part of the innate immune response and has exten- sive antimicrobial and immunomodulatory effects 10 30 that have been shown to influence the severity of pulmonary con- ditions and mortality in murine and human studies.

it is unclear from these data however whetherthe higher serum ll-37 levels preceded the infection were in response to it or were due to confounding by a third factor.haemophilusdominantstreptococcusdominant......2.28 1.25-4.17 .008c......1.57 .89-2.78 .12indeed neither these data nor previous studies have established causality between the serum level of ll-37 and severity of illness.

however given the underlying biology of ll-37 and the prepon-mixed......1.37 .79-2.41 .27abbreviations ci confidence interval or odds ratio rsv respiratory syncytial virus rv rhinovirus.adefined as admission to intensive care unit andor use of mechanical ventilation continu- ous positive airway pressure andor intubation during inpatient stay regardless of location at any time during the index hospitalization.bmixed-effects logistic regression model adjusting for sites as random effects.csignificant at p  .05.derance of data further study of ll-37 as a potential treatment for bronchiolitis requiring intensive care seems warranted.the present data suggest that higher circulating levels of ll-37 may be particularly useful for children with rsv bronchiolitis.

